201 related articles for article (PubMed ID: 1116468)
21. Vitamin-D intoxication during treatment of hypoparathyroidism.
Hossain M
Lancet; 1970 May; 1(7657):1149-51. PubMed ID: 4192101
[No Abstract] [Full Text] [Related]
22. [Hypoparathyroidism].
Fujita T
Naika; 1971 Jun; 27(6):1190-3. PubMed ID: 4326409
[No Abstract] [Full Text] [Related]
23. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
Okano K; Furukawa Y; Morii H; Fujita T
J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D intoxication treated with porcine calcitonin.
Buckle RM; Gamlen TR; Pullen IM
Br Med J; 1972 Jul; 3(5820):205-7. PubMed ID: 4261142
[TBL] [Abstract][Full Text] [Related]
25. The management of hypoparathyroidism with 1alpha-hydroxyvitamin D3.
Heyburn PJ; Peacock M
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():209s-214s. PubMed ID: 606418
[TBL] [Abstract][Full Text] [Related]
26. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
Chapuy MC; Chapuy P; Thomas JL; Hazard MC; Meunier PJ
Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
[TBL] [Abstract][Full Text] [Related]
27. [A case of urolithiasis due to vitamin D intoxication in a patient with idiopathic hypoparathyroidism].
Ichioka K; Moroi S; Yamamoto S; Kamoto T; Okuno H; Terai A; Terachi T; Ogawa O
Hinyokika Kiyo; 2002 Apr; 48(4):231-4. PubMed ID: 12048937
[TBL] [Abstract][Full Text] [Related]
28. [Sevelamer hydrochloride and vitamin D for controlling serum calcium, phosphorus and bone metabolism in patients undergoing hemodialysis].
Ishida M; Yao N; Yachiku S; Anzai T; Kobayashi T; Ishida H
Clin Calcium; 2005 Sep; 15 Suppl 1():192-9. PubMed ID: 16279024
[No Abstract] [Full Text] [Related]
29. Aspects of hypoparathyroidism: late diagnosis and toxic effects of therapy.
Dancaster CP
N Z Med J; 1980 Nov; 92(672):383-4. PubMed ID: 6937764
[TBL] [Abstract][Full Text] [Related]
30. [Vitamin D metabolites in a new case of drug-induced hypercalcemia (author's transl)].
Ulmann A; Bourdeau A; Lair M; Bader C
Nouv Presse Med; 1981 Oct; 10(36):2965-7. PubMed ID: 6974854
[TBL] [Abstract][Full Text] [Related]
31. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
32. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism.
Parfitt AM
J Clin Invest; 1972 Jul; 51(7):1879-88. PubMed ID: 4338123
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis].
Scharla SH
MMW Fortschr Med; 1999 Aug; 141(31-32):32-6. PubMed ID: 10726119
[TBL] [Abstract][Full Text] [Related]
34. Life-threatening complications of vitamin D intoxication due to over-the-counter supplements.
Kaptein S; Risselada AJ; Boerma EC; Egbers PH; Nieboer P
Clin Toxicol (Phila); 2010 Jun; 48(5):460-2. PubMed ID: 20515399
[TBL] [Abstract][Full Text] [Related]
35. Pseudohypoparathyroidism 1942-1966. A negative progress report.
Mautalen CA; Dymling JF; Horwith M
Am J Med; 1967 Jun; 42(6):977-85. PubMed ID: 4290849
[No Abstract] [Full Text] [Related]
36. [Preparations for treatment of hypoparathyreoidism (antitetanics). 36].
Götz HG
Pharm Prax; 1969; 7():158-60. PubMed ID: 4309760
[No Abstract] [Full Text] [Related]
37. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases.
Russell NJ; Bond KA; Robertson ID; Parry BW; Irwin PJ
Aust Vet J; 2006 Aug; 84(8):285-90. PubMed ID: 16911229
[TBL] [Abstract][Full Text] [Related]
38. The vitamin D endocrine system, calcium metabolism, and osteoporosis.
Slovik DM
Spec Top Endocrinol Metab; 1983; 5():83-148. PubMed ID: 6367121
[TBL] [Abstract][Full Text] [Related]
39. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
40. [Drug-induced hypercalcemia].
Sato K
Clin Calcium; 2006 Jan; 16(1):67-72. PubMed ID: 16397353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
